Clinical Trial Update: PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Sovateltide (PMZ-1620) in patients with acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Ischemia
• Stroke

Drugs mentioned

• Sovateltide (PMZ-1620) (sovateltide)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Acute Stroke, Cerebral Ischemia | Phase 2 | Status: COMPLETED